MediLogix

MediLogix Empowering Healthcare with AI 💡
Smarter documentation. Happier clinicians. Better care.
🌍 Trusted globally | 🏥 Built for healthcare

The 9pm charting complaint hides a bigger failure.Charting late is miserable. We hear about it constantly, and it's real...
08/11/2026

The 9pm charting complaint hides a bigger failure.

Charting late is miserable. We hear about it constantly, and it's real.

But the expensive part happens three days later.

A weekend clinician opens the chart and can't find the context. So the follow-up starts from zero. The escalation note is missing what coding needs, so reimbursement stalls on top of it.

That's the moment a slow note becomes a safety issue. And nobody names it until it already happened.

We built MediLogix around that second problem.

Every encounter becomes a structured record with attribution, linked back to the clinical context it came from. Different sites, different EHRs, weekend handoffs. One place, searchable, defensible.

The note taking too long is the cost you can see.

The handoff is where it actually breaks.

Every healthcare demo is built to hide your exact problem.Clean data. One perfect patient. A workflow nobody actually wo...
08/10/2026

Every healthcare demo is built to hide your exact problem.

Clean data. One perfect patient. A workflow nobody actually works in.

I sold in healthcare long enough to know how that pitch ends, and it isn't in the room. It ends six months later when the rollout stalls.

So when I demo MediLogix, I run the ugly stuff on purpose.

1. A clinician covering three sites, records scattered across systems
2. A Friday note that suddenly matters at 2am on Sunday
3. Someone on a different EHR who needs one patient record fast

Number 3 is where the room goes quiet.

Nothing flashy about it. They've just lived that exact moment, usually within the last week.

No pre-loaded patient. No script. If the platform can't handle a messy Tuesday, the demo lied.

Next time someone shows you software, ask for the edge cases. Watch what happens.

08/07/2026

The Reddit threads about AI documentation are right. Mostly.

Burned by a demo that never survived contact with a real clinic. A vendor who stopped answering after go-live. We've heard the same stories.

That skepticism is earned. We're not going to argue with it.

But the anger is pointed at the wrong thing.

The question was never whether AI documentation works. The question is what the tool was built for.

A lot of them were built for the demo room. Clean encounter, one EHR, a rep standing next to you.

We built for the other stuff.

The Friday handoff. Weekend coverage where the covering doc has never met the patient. The clinician working three sites who has never once had one place to find a record.

Actually, that last one is the whole reason MediLogix exists.

If a tool falls apart there, it was never a documentation tool. It was a sales tool.

So keep the skepticism. Just aim it at the right question.

Doctors skip your notes. Here's why.A doctor told me they scroll past 60 lines of pre-filled template to find one useful...
08/06/2026

Doctors skip your notes. Here's why.

A doctor told me they scroll past 60 lines of pre-filled template to find one useful sentence about the patient. Half the time that sentence isn't there. So they stopped reading nursing notes entirely.

That one stuck with me.

The note existed. It got signed. Legally it was fine.

But the person it was written for didn't read it.

I keep thinking about what the template actually documents. "GCS 13/15" with nothing after it. Not that the patient only opened their eyes to a trap squeeze. Not what calmed down the confused gentleman at 2am. Just the score.

The stuff a nurse actually did on that shift, the thing the next shift needs, that part gets skipped. Because after the charts and the care plans and four to ten patients, copy-paste is what's left.

I don't blame the nurse. The workload made that choice, not them.

But a note nobody reads still counts as risk. At handoff, at review, in front of a lawyer, the template version is what speaks for you.

Our whole reason for building what we build at MediLogix is that one useful sentence. The observation should be the easy part to capture, not the part that gets cut.

In some hospitals, an algorithm flags the stroke on a CT before the radiologist even opens the study.That flag decides w...
08/04/2026

In some hospitals, an algorithm flags the stroke on a CT before the radiologist even opens the study.

That flag decides which scan gets read in the next four minutes. The patient never hears a machine went first.

People ask me where AI actually sits in clinical work right now. Not the demos, the deployed stuff. It's a shorter list than the headlines suggest.

1. Radiology triage. Software watches the queue and bumps suspected strokes, bleeds, and pulmonary embolisms to the top. It doesn't diagnose. It reorders the line.

2. Documentation. Tools listen during the encounter and draft the note, the summary, the follow-up instructions. This is the part I've spent 25 years around, so I'll admit my attention lives here.

3. Coding support. Suggested codes pulled from the note before signature.

That's most of it. The scary sci-fi version, AI making the call on treatment, mostly isn't in production anywhere I've worked.

What I keep telling my team: the triage flag works because it's wired into the queue clinicians already use. Nobody opened a new app. The AI that survives in a hospital is the kind you stop noticing.

The documentation side has further to go. A draft note that doesn't hold up to an audit isn't a time saver, it's a liability with nice formatting.

We measure everything against one thing at MediLogix. Time back to the patient. The rest is noise.

78% have AI pilots. 14% got them into production.The pilot was the easy part. That last stretch, from demo to daily use,...
08/03/2026

78% have AI pilots. 14% got them into production.

The pilot was the easy part. That last stretch, from demo to daily use, is where these projects quietly die. Nobody puts that in the press release.

We've spent over two decades in healthcare technology, so we've had a front row seat to this a few times now.

Here's why pilots stall, in plain terms.

1. A pilot runs in a clean room. One team, one site, one workflow. Production means weekends, handoffs, three EHR systems, and a clinician who's already 40 minutes behind.

2. Pilots test the technology. Production tests the integration. Different question entirely.

3. Compliance gets bolted on at the end. In healthcare that's backwards. If the record isn't auditable and defensible, it doesn't matter how smart the summary is. You end up rebuilding.

The spending data for 2026 says the experiment phase is over. $2.59 trillion worldwide, up 47%. Organizations aren't testing anymore, they're building on it.

Which makes that 14% number uncomfortable. A working pilot is not a working system.

The fix, at least the one we've bet the company on: treat documentation as infrastructure from day one. Connect into what already exists instead of asking anyone to rebuild. Measure success by time returned to patient care, not features shipped.

If your pilot has been "about to scale" for six months, that's not caution.

That's the 78%.

Your AI scribe types fast. It understands nothing.It caught every word from the visit.It missed the patient who went qui...
07/31/2026

Your AI scribe types fast. It understands nothing.

It caught every word from the visit.

It missed the patient who went quiet when you mentioned the biopsy.

One of those two things changes the note that matters.

Here's how I think about it. Transcription answers one question: what was said. That's a solved problem. Has been for a while.

The harder question is what happened in the room.

A patient saying "I'm fine" flat, after a pause, is not the same encounter as a patient saying it easily. Same transcript. Different visit.

So we built MediLogix to read more than words. Tone. Stress signals. Whether the patient was actually engaged or just nodding through it.

Not to diagnose anything. That stays with the clinician. It should.

But when the next provider opens that record, they know what kind of conversation it was, not just what got said in it.

I used to think faster transcription was the goal. It's not even close. Speed just gets you a wrong picture sooner.

The transcript is the floor. The encounter is the point.

This week alone: a new flu subclade making rounds, another gene therapy approval, and a cardiac risk calculator quietly ...
07/28/2026

This week alone: a new flu subclade making rounds, another gene therapy approval, and a cardiac risk calculator quietly walked back after years of clinical use.

The volume is overwhelming. The quality is not.

So we stopped reacting to headlines and started running every health claim through the same four questions before we share it, act on it, or let it influence a clinical decision.

→ Who funded the study, and who benefits if the result is true?
→ What population was actually studied, and does it look anything like the patient in front of us?
→ Has the finding been replicated, or is this the first time anyone has reported it?
→ Was the endpoint something patients feel, or a surrogate marker that sounds impressive on a slide?

Four questions. That's it.

Most claims don't survive the first two.

Take the cardiac risk calculator story. It was used for years. It influenced statin prescribing for millions of people. And the underlying data was overestimating risk in some populations the whole time.

Nobody was acting in bad faith. The filters just weren't tight enough.

We work inside clinical documentation every day, so we see what happens when shaky claims get treated as settled science. They show up in notes, in treatment plans, in handoffs. The cost lands on patients.

Healthy skepticism is a form of respect for the people we're trying to help.

What filters do you run a health headline through before you trust it? Drop yours below if you've got one worth stealing. 👇

If you were diagnosed with a genetic disease today, you walked into a different medicine than someone diagnosed five yea...
07/27/2026

If you were diagnosed with a genetic disease today, you walked into a different medicine than someone diagnosed five years ago.

Your doctor might not frame it that way.

Gene therapy is approved for SMA. Experimental for Hunter syndrome. Trials running for conditions that had nothing in 2019.

But here's what often doesn't get said out loud at diagnosis:

→ Timing windows matter more than most people realize. Some therapies work dramatically better when started early. Weeks can change outcomes.

→ Genetic confirmation isn't optional. A clinical diagnosis is the starting point. The exact variant determines what you qualify for, what trials are open, what's coming.

→ Clinical trials aren't a last resort anymore. For some conditions, they're the front door.

→ Patient registries exist for almost every rare disease. They're how researchers find you when something new opens up.

→ The specialist who diagnosed you may not know what's in trials this quarter. That's not their failure. The field moves faster than any single clinician can track on their own.

You're walking into a system that's still catching up to its own progress.

The questions you ask in the first month often shape what's possible in year five.

If you've been through this, what would you add to the list? 👇

Cambridge researchers identified age 66 as the start of a new brain era.And almost everyone read that as bad news.It isn...
07/27/2026

Cambridge researchers identified age 66 as the start of a new brain era.
And almost everyone read that as bad news.

It isn't.

The study traces distinct phases across the human lifespan, and the fourth one begins around 66. Most people, including clinicians, hear "brain change after 60" and translate it instantly into decline. That translation is wrong more often than it's right.

Here's what the data actually says.

→ Processing speed slows. Yes.
→ Working memory capacity narrows. Sometimes.
→ Semantic knowledge keeps growing, often well into the late 70s.
→ Emotional regulation improves, measurably.
→ Pattern recognition deepens, because the pattern library is bigger.
→ Verbal reasoning stays remarkably stable.

We talk about aging brains as if every metric points the same direction. They don't. Some capacities soften. Others sharpen. A 70-year-old clinician reading a complex case is not running a degraded version of their 40-year-old self. They're running a different system with different strengths.

The decline narrative is inaccurate. And it's also harmful. It shapes how we document, how we counsel, how we treat. When a patient walks in at 68, the assumption underneath the encounter quietly changes the encounter itself.

We owe older patients a more honest read of their own neurology.

What do you think… is the way we talk about brain aging helping anyone, or quietly costing them?

Like and comment if you've ever had to push back on the decline assumption in your own practice.

Address

Naples, FL
34108

Website

Alerts

Be the first to know and let us send you an email when MediLogix posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MediLogix:

Shortcuts

Share

Category